GRCE — Grace Therapeutics, Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Grace Therapeutics,, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2021 March 31st	C2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	60.7	43.7	27.9	23	22.1
Net Total Receivables	0.53	0.548	0.802	0.722	0.126
Prepaid Expenses
Total Other Current Assets
Total Current Assets	62.4	45.3	29.3	24	22.7
Net Property, Plant And Equipment	0.086	0.565	0.567	0.024	0.015
Net Goodwill
Net Intangible Assets
Total Assets	62.5	129	79.1	73.3	72
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	1.58	3.26	3.41	1.68	1.93
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	6.8	20.4	11.2	11.6	5.38
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	55.7	108	68	61.7	66.6
Total Liabilities & Shareholders' Equity	62.5	129	79.1	73.3	72
Total Common Shares Outstanding